Senate bill aims to soothe helium market


The US Senate has passed a bill that will let the government continue selling off its stockpiled helium, in an attempt to prevent a disruption of supply that could adversely affect researchers around the world. Currently, sales of the American stockpile, mainly built up during the cold war, supply 42% of the US and and 35% of global demand for the gas. 

In 1996, US lawmakers ordered the sale of the federal helium stores to pay off the accumulated debts of $1.3 billion (£840 million) of the US Federal Helium Reserve in Amarillo, Texas. However, the sell off is set to end in October as the facility's debts have been settled. Global production elsewhere is unable to meet current demands and researchers around the world had warned the 'helium cliff' could severely affect global research and development if the US reduces exports of the gas. However, while the sale looks set to continue, the price of helium is expected to rise. The current sell off has supressed the market value for helium and discouraged conservation and exploration for new sources. 

The bill will now move to the the House of Representatives, which passed a similar bill back in April. The Senate and Representatives bills are similar but differ slightly in how the remaining helium will be sold off and what will be done with the proceeds.


Related Content

US chemical safety law poised for reform in early 2016

23 December 2015 News and Analysis

news image

Bill updating the US Toxic Substances Control Act has finally passed both chambers of Congress

Deal reached on US chemical regulation reform

20 May 2016 News and Analysis

news image

Modernisation of America’s outdated Toxic Substances Control Act agreed, and expected to be signed into law imminently 

Most Commented

WHO clarifies glyphosate risks

23 May 2016 Business

news image

UN and WHO panel conclude the herbicide glyphosate is ‘unlikely’ to cause cancer at realistic exposure levels

Large HIV vaccine trial to launch in South Africa

24 May 2016 News and Analysis

news image

US funding agency will enlist 5400 people for HIV vaccine study in South Africa in November